The report highlights Genmab's commitment to building a sustainable and socially responsible biotech, driven by its core purpose ""to improve the lives of patients by creating and developing innovative antibody products."" The company highlights its focus on employee well-being, ethical business practices, environmental responsibility, and the implementation of a business-driven CSR strategy. The report also details Genmab's progress towards achieving its 2025 Vision and its commitment to the United Nations Sustainable Development Goals, particularly Goal 3 (Good Health and Well-being), Goal 5 (Gender Equality), and Goal 8 (Decent Work and Economic Growth).
Issuing Company Genmab A/S
Report Type Sustainability Report
Report Language EN
Report Filesize 2.76 MB
No. of Pages 26 pages
Reporting periodJanuary 1-December 31, 2020
Report EditionUnknown
Assurance Provider Unknown
Reporting Standards GRI; SASB; UNSDGs
Materiality Assessmenttrue
